CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Thomas Reilly

OPENALEX: A5026780309↗ORCID: 0000-0001-6890-918X↗

Affiliations

Organizations

King's College Londonauthorship · GB King's College Schoolauthorship · GB South London and Maudsley NHS Foundation Trustauthorship · GB University of Oxfordauthorship · GB

Public evidence

1 connected articles

Novel Lipid Formulation Increases Absorption of Oral Cannabidiol (CBD).2024 · Europe PMC

Registered research

Connected studies

Pharmacokinetic Study of a Novel Lipid Formulation of Cannabidiol Compared to a Standard Formulationnct05032807

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.

Thomas Reilly - Medical Cannabis Research Engine